Browsing by Author "Montero, Núria"

Sort by: Order: Results:

  • Artificial intelligence for the artificial kidney: pointers to the future of a personalized hemodialysis therapy
    Hueso Val, Miquel; Vellido Alcacena, Alfredo; Montero, Núria; Barbieri, Carlo; Ramos, Rosa; Angoso de Guzmán, Manuel; Cruzado, Josep Ma.; Jonsson, Anders, 1973- (Karger (S. Karger AG), 2018)
    Current dialysis devices are not able to react when unexpected changes occur during dialysis treatment or to learn about experience for therapy personalization. Furthermore, great efforts are dedicated to develop miniaturized ...
  • Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
    Toapanta, Néstor; Jiménez, Sara; Molina-Gómez, María; Maruri-Kareaga, Naroa; Llinàs-Mallol, Laura; Villanego, Florentino; Facundo, Carme; Rodríguez-Ferrero, Marisa; Montero, Núria; Vázquez-Sanchez, Teresa; Gutiérrez-Dalmau, Alex; Beneyto, Maria Isabel; Franco, Antonio; Hernández-Vicente, Ana; Pérez-Tamajon, M. Lourdes; Martín, Paloma; Ramos-Verde, Ana María; Castañeda, Zaira; Bestard, Oriol; Moreso, Francesc (Oxford University Press, 2022)
    Coronavirus disease 2019 (COVID-19) in kidney transplant recipients has a high risk of complications and mortality, especially in older recipients diagnosed during the early period after transplantation. Management of ...
  • Mammalian target of rapamycin inhibitors combined with Calcineurin inhibitors as initial immunosuppression in renal transplantation: a meta-analysis
    Montero, Núria; Quero, Maria; Melilli, Edoardo; Pérez-Sáez, María José; Redondo Pachón, María Dolores; Bestard, Oriol; Crespo Barrio, Marta; Cruzado, Josep Ma.; Pascual Santos, Julio (Lippincott Williams & Wilkins, 2019)
    Background: The current standard of care immunosuppressive regimen in kidney transplantation (KT) includes a combination of mycophenolates (MMF/MPA) with a calcineurin inhibitor (CNI). Methods: We designed a systematic ...